Evid Invest
Holders — by stockHoldings — by fund

TCG Crossover Management, LLC

Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001839948

$3.54B

disclosed book value

57

positions

10.2%

largest position share

Positions, as of 2026-09-30

top 57 of 57 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held

#IssuerSharesValue% of book
1ABVXABIVAX SA AMERICAN DEPOSITARY SHARES3.7M$362.7M10.2%
2CGONCG ONCOLOGY INC3.7M$260.2M7.4%
3AMLXAMYLYX PHARMACEUTICALS INC6.2M$181.7M5.1%
4SYRESPYRE THERAPEUTICS INC1.9M$169.2M4.8%
5TNGXTANGO THERAPEUTICS INC6.8M$169.0M4.8%
6ZLABZAI LAB LTD-ADR6.2M$164.1M4.6%
7IMVTIMMUNOVANT INC4.5M$150.6M4.3%
8DNTHDIANTHUS THERAPEUTICS INC1.7M$147.6M4.2%
9KRSAKORSANA BIOSCIENCES INC4.5M$145.6M4.1%
10KODKODIAK SCIENCES INC1.4M$137.0M3.9%
11VORVOR BIOPHARMA INC5.7M$108.2M3.1%
12TRAXFIRST TRACKS BIOTHERAPEUTICS2.9M$102.6M2.9%
13MIRMMIRUM PHARMACEUTICALS INC1.1M$95.6M2.7%
14BCRXBIOCRYST PHARMACEUTICALS INC11.0M$91.8M2.6%
15IRONDISC MEDICINE INC1.3M$87.8M2.5%
16ADRXADARX PHARMACEUTICALS INC4.1M$82.1M2.3%
17COGTCOGENT BIOSCIENCES INC2.5M$80.1M2.3%
18TYRATYRA BIOSCIENCES INC3.5M$76.0M2.1%
19DYNDYNE THERAPEUTICS INC4.6M$74.3M2.1%
20RLAYRELAY THERAPEUTICS INC3.8M$68.3M1.9%
21AURAAURA BIOSCIENCES INC10.2M$63.8M1.8%
22SVRASAVARA INC12.4M$63.8M1.8%
23XNCRXENCOR INC2.1M$51.3M1.4%
24AVTXAVALO THERAPEUTICS INC3.0M$46.3M1.3%
25GLUEMONTE ROSA THERAPEUTICS INC3.8M$45.1M1.3%
26MBXMBX BIOSCIENCES INC650,000$38.1M1.1%
27ENTXENTERA BIO LTD12.3M$35.7M1%
28JANXJANUX THERAPEUTICS INC1.8M$30.9M0.9%
29TARSTARSUS PHARMACEUTICALS INC388,164$30.5M0.9%
30IPSCCENTURY THERAPEUTICS INC17.8M$30.4M0.9%
31OBXOBSIDIAN THERAPEUTICS INC2.2M$30.2M0.9%
32PHVSPHARVARIS BV947,544$30.1M0.8%
33LBRXLB PHARMACEUTICALS INC765,050$29.4M0.8%
34EDITEDITAS MEDICINE INC11.1M$28.6M0.8%
35TECXTECTONIC THERAPEUTIC INC1.2M$28.1M0.8%
36IFRXINFLARX N V14.5M$26.1M0.7%
37CATXPERSPECTIVE THERAPEUTICS INC7.9M$21.8M0.6%
38AGMBAGOMAB THERAPEUTICS NV1.8M$20.2M0.6%
39SLNSILENCE THERAPEUTICS PLC1.8M$19.9M0.6%
40ALECALECTOR INC10.0M$18.5M0.5%
41BHVNBIOHAVEN LTD1.3M$16.9M0.5%
42MNPRMONOPAR THERAPEUTICS INC202,242$16.1M0.5%
43ADCTADC THERAPEUTICS SA11.4M$13.9M0.4%
44TRDAENTRADA THERAPEUTICS INC1.1M$6.7M0.2%
45CGEMCULLINAN THERAPEUTICS INC406,786$6.2M0.2%
46AGENAGENUS INC603,892$6.0M0.2%
47OCULOCULAR THERAPEUTIX INC720,323$5.5M0.2%
48ARVNARVINAS INC707,098$5.5M0.2%
49KRROKORRO BIO INC416,301$4.1M0.1%
50RACDRESEARCH ALLIANCE CORP IV-A300,000$3.6M0.1%
51ALXOALX ONCOLOGY HOLDINGS INC2.5M$3.4M0.1%
52AKTSAKTIS ONCOLOGY INC133,457$2.6M0.1%
53JATTJATT II ACQUISITION CORP200,000$2.2M0.1%
54LONALEONABIO INC464,398$1.7M0%
55JTTTJATT III ACQUISITION CORP100,000$1.1M0%
56CNTXCONTEXT THERAPEUTICS INC2.7M$805,8820%
57EIKNEIKON THERAPEUTICS INC37,902$304,7320%

Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.